SEC Form 4 · accession 0001237899-15-000054
REGENERON PHARMACEUTICALS, INC. · REGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
P Roy Vagelos
Officer — Chairman of the Board · Director
Period of report
Nov 18, 2015
Accepted (ET)
Nov 19, 2015 · 4:20 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000872589
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 18, 2015 | S | 10,227 | $588.40 | D | 341,624 | D | |
| Common StockF2 | Nov 18, 2015 | S | 3,539 | $587.58 | D | 338,085 | D | |
| Common StockF3 | Nov 18, 2015 | S | 3,474 | $586.73 | D | 334,611 | D | |
| Common Stock | Nov 19, 2015 | G | 1,731 | $0.00 | D | 332,880 | D | |
| Common Stock | Oct 1, 2015 | G | 455 | $0.00 | D | 153,935 | I | by CLAT |
| Common Stock | holding | — | — | — | 2,282 | I | By 401(k) Plan | |
| Common Stock | holding | — | — | — | 92,947 | I | by Spouse as Trustee | |
| Common StockF4 | holding | — | — | — | 1,203 | I | by trust for grandch |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents volume-weighted average price of sales of 10,227 shares of Company stock on November 18, 2015 at prices ranging from $588.00 to $588.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2015 at each separate price.
- F2Represents volume-weighted average price of sales of 3,539 shares of Company stock on November 18, 2015 at prices ranging from $587.10 to $587.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2015 at each separate price.
- F3Represents volume-weighted average price of sales of 3,474 shares of Company stock on November 18, 2015 at prices ranging from $586.64 to $586.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 18, 2015 at each separate price.
- F4By a trust for the benefit of certain grandchildren of the reporting person, of which the reporting person and/or the spouse of the reporting person is trustee.